GlobeNewswire🇺🇸 USAchieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA22 June 2026 at 14:30 CESTCRL Cites Deficiencies at Third-Party Manufacturing FacilityRead full release on GlobeNewswire
